6 results
DEF 14C
BGLC
BioNexus Gene Lab Corp
29 Feb 24
Information statement
5:16pm
on the Company's profitability and are prohibited.
6.2 All Company assets should be used only for legitimate business purposes. Any suspected incident
PRE 14C
BGLC
BioNexus Gene Lab Corp
26 Jan 24
Preliminary information
4:05pm
on the Company's profitability and are prohibited.
6.2 All Company assets should be used only for legitimate business purposes. Any suspected incident
8-K
EX-1.1
BGLC
BioNexus Gene Lab Corp
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
to be paid all costs and expenses incident to the performance of its obligations hereunder, including, without limitation, (i) all expenses incident … Stock, and (xi) all other expenses incident to the performance by the Company of its other obligations under this Agreement; provided that the actual
- Prev
- 1
- Next